Guardant Health, Inc.
Guardant Health, Inc. (GH) — Form 144: Proposed sale of shares
AI-generated summary
Officer Monroe Terilyn J. of Guardant Health, Inc. proposed to sell 3,842 common shares with an aggregate market value of $547,149 through Charles Schwab & Co., Inc. on approximately November 18, 2026. The shares to be sold were acquired through restricted stock lapses of 1,921 shares on July 1, 2026, and 1,921 shares on October 1, 2026. The proposed sale was made under a trading plan adopted on August 19, 2026.
Key facts
- Seller
- Monroe Terilyn J.
- Relationship
- Officer
- Shares to sell
- 3,842
- Market value
- $547,149.00
- Approximate sale date
- Nov 18, 2026
- Broker
- Charles Schwab & Co., Inc.
- Acquired (1)
- Jul 1, 2026 · Restricted Stock Lapse
- Acquired (2)
- Oct 1, 2026 · Restricted Stock Lapse
Rule 10b5-1 plan · adopted Aug 19, 2026
More GH filings
- 4
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 17, 2026
- 4
Filed Nov 17, 2026
- 144
Filed Nov 16, 2026
- 144
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.